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Human coagulation factor IX serves both to maintain
and to control blood coagulation. The dual function
of this hemophilic factor is implemented by a tiered
activation mechanism. Processed two-chain factor
IXa is catalytically silent; only together with its
cofactor VIIIa does factor IXa form the highly potent
Xase complex. The detailed mechanism of this
secondary activation has remained elusive so far.
Here we present the crystal structures of Xase-
like factor IXa mutants with several-thousand-fold
activity enhancement that mimic the secondary acti-
vation by Xase formation. The structures reveal how
cofactor-triggered and substrate-assisted modula-
tions in the factor IXa 99- and 60-loops cooperate
in S4 through S20 formation, allowing for productive
substrate recognition. We could further physically
map and visualize a distinct communication line,
alongwhich agonists such as Ca2+ direct their effects
to the active site and vice versa.
INTRODUCTION
The human coagulation cascade is an interdependent system of
serine proteases, their cofactors, and inhibitors. This complex
protease machinery rapidly stops life-threatening blood loss
caused by vasculature lesions, while avoiding uncontrolled clot
formation (thrombosis). To this end, the involved proteins are
produced on stock as inactive precursors, which are readily con-
verted to the active form by proteolytic cleavage; however, they
reveal their full catalytic potency only through further stimulating
events like complex formation with cofactors (Zo¨gg and Brand-
stetter, 2009).
Upon vessel injury, the coagulation cascade is initiated by the
exposure of tissue factor protein to the blood stream. Tissue
factor forms a membrane-associated complex with the protease
factor VIIa (Josso and Prou-Wartelle, 1965; Osterud and Rapa-
port, 1977), which together act as extrinsic Xase (factor X con-
verting enzyme complex) that gives rise to a locally restricted
procoagulant signal. Sustained blood coagulation further
requires activated factor IX (fIXa) to form a Ca2+-dependent
complex with the cofactor fVIIIa on phospholipid membranesStructure 17, 1669–1(van Dieijen et al., 1981), known as the intrinsic Xase complex.
Defects in fVIIIa and fIXa manifest themselves clinically in the
bleeding disorders hemophilia A and B, respectively, and thus
witness the significance of the intrinsic Xase for blood coagula-
tion (Reitter et al., 2009).
Coagulation factor IX is synthesized as a multidomain single-
chain protein that circulates in the bloodstream. In a first phase of
activation, the activation peptide spanning Ala146abs-Arg180abs
(absolute sequence numbering) is released by two cleavages
(Fujikawa et al., 1974; Kurachi and Davie, 1982; Lollar et al.,
1987). Cleavage at the Arg180abs-Val181abs peptide bond
forms the two-chain protein fIXaa; the resulting new N termi-
nus (Val181abs h Val16; chymotrypsinogen numbering, used
throughout for the catalytic domain) forms a salt bridge with
Asp194 within the activation pocket and thus induces the active
protease conformation (Lindquist et al., 1978). The second
cleavage at Arg145abs-Ala146abs, resulting in fIXab, is required
for efficient cofactor binding (Lenting et al., 1995).
Activity of fIXa alone is extremely poor, however (Byrne et al.,
1980; McRae et al., 1981). Therefore, the complex formation with
cofactor fVIIIa represents a critical second phase of activation,
after which the intrinsic Xase complex reaches an approximately
200,000-fold enhanced activity that is strictly specific toward the
physiological substrate fX and restricted to the surface of acti-
vated platelets (van Dieijen et al., 1981). This macromolecular
activation is assisted by low-molecular-weight agonists, includ-
ing Ca2+ (Amphlett et al., 1981; Mathur et al., 1997; Morita et al.,
1984). Several lines of evidence indicate that Ca2+ binding is
accompanied by a conformational rearrangement (Bajaj et al.,
1992; Enfield and Thompson, 1984).
Whereas the exact details of Xase-complex formation and
activation remain elusive to date, massive effort has been
directed toward its modeling by low-molecular-weight effectors
such as ethylene glycol and glycerol and by designing superac-
tive Xase-like mutants of fIXa, resulting in an up to 20-fold and
several-thousand-fold activity increase, respectively (Sichler
et al., 2003; Stu¨rzebecher et al., 1997).
Here we present the crystal structures of Xase-like fIXa vari-
ants that illustrate a synergistic conformational activation mech-
anism. Moreover, these structures provide a detailed and fully
consistent atomic model of the physiological activity enhance-
ment of fIXa by both Xase formation and the substrate fX. Addi-
tionally, by applying difference Fourier-based techniques, we
visualize distinct communication lines interconnecting distant
regulatory sites in the protein.678, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1669
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Structure and Mechanism of Xase-like fIXa MutantsTable 1. Data Collection and Refinement Statistics
Mutant fIXa_2 fIXa_3 fIXa_3 +EGR fIXa_3 + EG fIXa_3 + EDTA fIXa_3 + Na+
PDB ID 2wpi 2wph 2wpm 2wpk 2wpl 2wpj
Additive — — EGR-CMK ethylene glycol EDTA NaCl
Resolution range (A˚) 29.6 - 2.0 7.0 - 1.5 21.7 - 2.0 21.6 - 2.2 31.6 - 1.8 20.0 - 1.6
Space group P212121 P212121 P212121 P212121 P212121 P212121
Molecules in ASU 1 1 1 1 1 1
Unit cell dimensions
a 44.3 44.3 44.2 44.1 44.4 44.1
b 67.4 66.5 66.8 66.5 66.7 66.2
c 98.3 97.6 96.8 96.7 98.3 97.0
Data Collection and Refinement
Measured reflections 114070 356205 88802 100963 105214 188171
Unique reflections 16881 44244 16727 14747 22189 33309
Completeness (%) (outer shell) 81.0 (99.0) 94.5 (81.1) 83.6 (68.8) 99.7 (86.6) 82.4 (71.4) 87.1 (99.6)
Multiplicity (outer shell) 6.7 (6.5) 7.8 (6.3) 5.1 (4.9) 6.8 (6.6) 4.7 (4.6) 5.6 (5.5)
Rpim (outer shell) 0.065 (0.177) 0.027 (0.258) 0.061 (0.339) 0.028 (0.111) 0.034 (0.323) 0.026 (0.097)
Rmerge (outer shell) 0.161 (0.429) 0.080 (0.615) 0.128 (0.706) 0.067 (0.265) 0.068 (0.637) 0.057 (0.215)
Mean (<I > /sd < I >) (outer shell) 6.5 (3.1) 19.1 (2.0) 11.5 (2.0) 22.9 (6.7) 13.0 (2.4) 20.7 (5.9)
Rcrys (Rfree) 0.205 (0.252) 0.240 (0.267) 0.230 (0.318) 0.206 (0.259) 0.227 (0.289) 0.206 (0.256)
Rmsd from ideal geometry
Bond length 0.008 0.013 0.008 0.008 0.010 0.015
Bond angles 1.482 1.843 1.483 1.457 1.574 1.813
Ramachandran statistics (%)
preferred / allowed / outliers
87 / 13 / 0 86 / 14 / 0 84 / 15 / 1 84 / 16 / 0 86 / 14 / 0 83 / 17 / 0RESULTS
99- and 60-Loop Reordering in the Xase-like Mutants
Previously, we identified the factor IXa triple mutant Y94F-
K98T-Y177T (referred to as fIXa_3) with several-thousand-fold
increased catalytic activity. This feature resembles essential
properties found in Xase activation, where a 100,000-fold
increase in the kinetic parameters (kcat, KM) is observed (Sichler
et al., 2003; van Dieijen et al., 1981). We could further show that
the double mutant K98T-Y177T (fIXa_2) exhibits an even higher
(1.5-fold) activity when compared with fIXa_3 (data not shown).
The stimulation of both the double and triple mutant cannot be
explained by an additive effect of the moderately active single
mutations K98T and Y177T, yielding approximately 8-fold and
2-fold acceleration—it is synergistic in its nature, resulting in
a several-thousand-fold enhancement. This cooperative activa-
tion resembles that of fIXa activation by Xase-complex formation
both functionally and presumably also conformationally (Sichler
et al., 2003).
To elucidate the detailed activation mechanism of these Xase-
like fIXa mutants, we determined their crystal structures at reso-
lutions of 1.5 A˚ and 2.0 A˚ (Table 1). The structures of human
wild-type fIXa (Protein Data Bank [PDB] code 1rfn) and human
fXa (PDB code 1fax) served as a reference to analyze structural
reorganizations of the Xase-like mutants (Brandstetter et al.,
1996; Hopfner et al., 1999).
Both in fIXa_2 and fIXa_3 the most striking rearrangements
occur in the backbone chain trace from residues Tyr94 to Tyr99
of the 99-loop, known to restrict substrate binding (Kolkman and1670 Structure 17, 1669–1678, December 9, 2009 ª2009 Elsevier LMertens, 2000). The two Xase-like mutants adopt an almost
identical three-dimensional structure in the 99-loop, indicating
that the observed rearrangements are triggered by the shared
mutations K98T and Y177T. In stark contrast to the wild-type
structure, the 99-loop in the Xase-like mutants is stabilized in a
compacted conformation via new hydrogen bonds from Thr98-
Og to the amide-nitrogen of Asn100 as well as Asn100-Od to
Thr177-Og (overview in Figure 1A, detail in Figure 1B). The
observed main-chain rearrangements explain why single site
mutations fell short of the expectations in activity enhancement
(Hopfner et al., 1997).
To further elucidate the role of the observed 99-loop rear-
rangement, it proves instructive to compare its structures with
that of the homologous, yet highly active fXa. Remarkably, the
backbone of the 99-loop of fIXa_2 closely follows the chain trace
of fXa, except for the fIX-specific insertion of the two extra amino
acids Ala95a and Ala95b (Figure 1B). The electron density at this
segment is well defined at a high contouring level, reflecting the
favorable energy of the 99-loop conformation in the superactive
mutants and contrasting the situation in wild-type fIXa (Brand-
stetter et al., 1995; Hopfner et al., 1999).
The conformation of the 99-loop in the Xase-like mutants is
compatible with efficient and productive substrate binding, and
thus improves both KM (substrate affinity) and kcat (productivity
of substrate binding) of the catalyzed reaction (Figures 1A; see
Figure S1 available online). Interestingly, the side-chain positions
of Tyr99 converge within less than 1 A˚ in the fIXa wild-type and
Xase-like mutant structures, although their main-chain Ca posi-
tions deviate for almost 2 A˚.td All rights reserved
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Structure and Mechanism of Xase-like fIXa MutantsAmong the coagulation factors, tyrosine at position 94 is
specific to fIXa. Whereas its hydroxyl group forms a hydrogen
bond with the carbonyl oxygen of Lys98 in wild-type fIXa, the
reordering of the 99-loop in the Xase-like mutants excludes
such a stabilizing interaction. Instead, in fIXa_2, the Tyr94 shifts
for 1.1 A˚ and its hydroxyl forms a new hydrogen bond with the
carboxyl of Glu60 (Figure 1C). Because fIXa_3 contains the addi-
tional Y94F mutation, this interaction to Glu60 is not possible.
Instead, the lack of stabilizing interactions results in an alterna-
tive conformation in the 60-loop in the two Xase-like mutants
(Figure S2). The 60-loop is reordered and stabilized in fIXa_2
by the Glu60-Tyr94 interaction, while fIXa_3 exhibits a wild-
type-like 60-loop conformation that is partially disordered.
Figure 1. Comparison of 99-Loop Conformations in Wild-Type fIXa,
Superactive fIXa Mutants, and fXa
(A) Overview of the catalytic domain of fIXa. Important loop areas are indicated
in red. The side chains of relevant residues are shown as stick model in green
and, for the catalytic triad, in yellow. The active site is occupied by the
substrate analog FPR-CMK depicted in stick and surface representation.
A detailed comparison of inhibitor binding modes (FPR-CMK and EGR-
CMK) is given in Figure S1.
(B) Superposition of fIXa_2 (blue) and homologous fXa (yellow); stabilizing
hydrogen bonds in fIXa_2 are indicated by dotted lines. The coordinates of
the relevant loop residues T98, D100/N100, and T177 are virtually identical.
(C) Superposition of wild-type fIXa (yellow) and fIXa_2 (gray) in the 99-loop and
60-loop areas. In wild-type fIXa, the 99-loop conformation is locked by the
Y94–K98 hydrogen bond, indicated by a yellow dotted line. In fIXa_2, the posi-
tion of T98 is significantly reoriented as compared to K98 in wild-type fIXa. As
a consequence, Y94 moves for 1.1 A˚, enabling its hydroxyl to form a hydrogen
bond with E60 (gray dotted line). A comparison of the situation in fIXa_2 and
fIXa_3 lacking Y94 and therefore missing this stabilizing interaction is given
in Figure S2. Superposition of structures was prepared using the TopMatch
web server (Sippl and Wiederstein, 2008). All molecular figures were prepared
with PyMOL (DeLano, 2005).Structure 17, 1669–1A straightforward translation of the underlying mechanism into
the physiological Xase complex involves two synergistically
operating steps, namely (1) the destabilization of the unproduc-
tive 99-loop conformation by cofactor fVIIIa, followed by (2) the
mutual stabilization of the 99-loop and the 60-loop in a produc-
tive Xase-like conformation (Figure 2). The fIXa_2 structure
shows that the latter interaction (2) can be triggered by a scissile
peptide bond-bridging substrate, such as fX. Together, these
steps result in a stabilization of the complete northern rim of
the fIXa active site.
Polar S4 and Adaptive S2 Sites in Xase-like fIXa
To perform comparative inhibitor binding studies, Xase-like
fIXa mutants were blocked with either the substrate analog
D-phenylalanyl-prolyl-arginyl-chloromethyl ketone (FPR-CMK,
aka ‘‘PPACK’’) or with glutamyl-glycyl-arginyl-chloromethyl
ketone ‘‘EGR-CMK.’’ Apart from the glutamate side chain of
EGR-CMK, both inhibitors are well defined in the electron
density, revealing a canonical S1-S3 inhibitor binding mode
and covalent bonds to the catalytic residues Ser195 and His57.
Of particular interest are the interactions with the S4 and S2 sites.
The D-chirality in FPR-CMK allows the P3 side chain to orient
toward the canonical S4 site rather than to the solvent. However,
the fit of the phenylalanine side chain remains incomplete
(Figures 3B and S1), as compared with, and contrasted by, the
binding of PPACK to thrombin’s aryl-binding site (S4 site) (Bode
et al., 1989). This imperfect interaction can be attributed to an
array of three polar groups positioned toward the S4 site (the
carbonyl oxygens of Asn98a and Thr98b, and the side chain
of Asn95), rendering the S4 site attractive to basic or polar P4
residues rather than hydrophobic or aromatic P4 residues. The
reorganization of 99-loop thus explains the selectivity of the
Xase complex for f three polar groups positioned toward the S4
site (the carbonyl oxygens of Asn98a and Thr98b, and the side
chain polar and basic P4 substrates (with natural substrate
cleavage sites being NLTR in fX and KLTR in fIX, respectively).
Similar as in the related fXa, the S2 site in fIXa is dominated by
Tyr99. To avoid a steric conflict with the bulky P2 proline, the
Tyr99 side chain undergoes an approximate 30 c1-rotation,
as compared with the EGR-CMK complex structure (Figures
3B and S1). We expect a similar Tyr99-conformer in complex
with the physiological substrate bearing threonine at P2 (Castillo
et al., 1983; Cho et al., 1984). Tyr99 in fIXa confers adaptivity to
the substrate, which is not observed in the related fXa.
Identification of a Novel EG Binding Site Explains
its Stabilizing and Stimulating Effect
Ethylene glycol (EG) recently attracted large interest because of
its significant activity enhancement in fIXa (20-fold) and fVIIa
(5-fold) (Sichler et al., 2003; Stu¨rzebecher et al., 1997). Structural
studies identified an EG binding site in factor VIIa (fVIIa), located
between the 60- and the 99-loop (Sichler et al., 2002). We
hypothesized that EG could similarly bind in fIXa, given an anal-
ogous activity stimulation in fVIIa and fIXa (Neuenschwander
et al., 1993; Sichler et al., 2002).
Notably, by analysis of EG-soaked crystal data we could not
detect an alcohol molecule bound at this putative binding site.
Instead, we found a tubular density near the active site which
was convincingly interpreted as an EG molecule (Figure 3A).678, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1671
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1672 Structure 17, 1669–1678, December 9, 2009 ª2009 ElsevierEG forms hydrogen bonds with the Ser171 Og, the carbonyl
oxygen and amide nitrogen of Tyr225 and the amide nitrogen
of Glu217. The EG molecule directly interacts with the S3 site
(Gly216; 3.5 A˚) and influences the S1 and the S4 sites located
at distances of 6.0 A˚ and 7.0 A˚, respectively (Figure 3B). The
structure thus provides a rationale to explain the activity stimula-
tion by EG, as discussed in more detail below.
A Long-Range Communication Line Connects the Ca2+
Exosite with the Active Site
To study the calcium-dependent conformational changes, Ca2+
was extracted from the crystals by soaking them with EDTA.
Removal of Ca2+ in the EDTA-treated crystals manifested itself
by a 120 backbone twist of the calcium-coordinating residue
Glu77 (Figure 4A). This reorganization was accompanied by
a change in the Thr76 sidechain. Otherwise, the inner coordination
sphere around the empty Ca2+ site remained largely unchanged.
Significantly, the perturbations upon calcium extraction are
not isotropic and uniform, but propagate through the protease
domain in a directed, wired-like connection to the active site.
Important residues involved in signal transfer include Asp21-
Trp141-Val154 near the calcium loop, Val16-Gly193-Asp194 at
the activation pocket, and the Cys191-Cys220 disulfide bond
that connects the oxyanion hole with the nonprimed substrate
recognition sites. We could visualize this molecular communica-
tion line directly from experimental data by the isomorphous dif-
ference electron density of the calcium-loaded and the calcium-
free fIXa structures (Figure 4B; see Experimental Procedures for
more details). Notably, the changes along the communication
line are not generally recognizable in the static structure in terms
of alternate coordinates, but in the dynamics of the contributing
residues, which were detected via changes in their diffraction
power. The effects upon Ca2+ extraction are likely to be damp-
ened by the PPACK-inhibitor, which is covalently bound to the
active site.
The fIXa-Specific EGG Motif within the 186-Loop
and His185-Tyr225 Bonding Suppress Na+ Binding
Sodium binding has been proposed to function as a central regu-
lation mechanism in most, if not all, coagulation proteases (Dang
and Di Cera, 1996; Page and Di Cera, 2006). However, kinetic
data of Na+-effects on fIXa are conflicting, ranging from minimal
to strong impact (Gopalakrishna and Rezaie, 2006; Schmidt
et al., 2005).
Figure 2. Sequential Activation of fIXa Activation by the Cofactor
fVIIIa and the Substrate fX
(A) In the absence of fVIIIa and fX, substrate access to the fIXa active site is
sterically and electrostatically blocked by the 99-loop. This unproductive
conformation is stabilized by interactions within the 99-loop and with Y177.
Flexibility in the 60-loop further hinders substrate binding.
(B) The presence of fVIIIa alone unlocks the unproductive fIXa 99-loop, but
does not generate a conformation consistent with productive substrate
binding and turnover. Consequently, the turnover of para-nitroanilide
substrates is not enhanced in the presence of fVIIIa (Kolkman and Mertens,
2000).
(C) Only concerted action by fVIIIa and fX, as realized in the intrinsic Xase
complex, results in a stabilized rearrangement of the chain trace in the
99-loop and the 60-loop that translate into highly efficient fX turnover.Ltd All rights reserved
Structure
Structure and Mechanism of Xase-like fIXa MutantsWe addressed the Na+ interaction by crystal structure analysis
of the Xase-like fIXa variants under various experimental condi-
tions, including soaking experiments at concentrations far above
physiological levels. None of these structural analyses revealed
evidence for sodium binding, notwithstanding the superb quality
of the electron densities at 1.6 A˚ resolution (Figure 5A, electron
density in Figure 5B). Instead, three water molecules were
observed, sharing typical hydrogen bond distances (2.8 A˚),
whereas sodium binding is characterized by bonding distances
of 2.3 to 2.5 A˚ with an octahedral coordination sphere (Harding,
2002). We found the (putative) Na+ site unoccupied both in the
presence and the absence of ethylene glycol and Ca2+.
In order to understand the absence of Na+, we compared the
here reported fIXa structure with two fXa structures that were
determined in the presence and the absence of Na+ (PDB entry
codes 2bok [Scha¨rer et al., 2005] and 1fjs [Adler et al., 2000],
respectively).
The carbonyl oxygens of residues 222 and 224 form two of the
four protein ligands to the sodium ion in the 2bok structure; these
carbonyls are virtually identical in all three structures, as is the
complete 217-225-loop. By contrast, the other two protein-
derived sodium ligands, the carbonyls of Tyr185 and Asp185a,
show distinct deviations in the three compared structures, consis-
tent withcation selectivity studies in thrombin (Prasadet al., 2003):
The Na+-loaded fXa structure reveals a compressed binding site
with the carbonyl oxygens of the 186-loop in ideal binding geom-
etry with approximately 2.3 A˚ bond lengths to the sodium ion
(Figures 5C and 5E, yellow structure). A 1.0 A˚ relocation of this
loop in the Na+-free fXa structure expands the site and prevents
ion binding (not shown). Additionally, the 186-loop is more disor-
dered, exemplified by the Asp185a side chain that is not defined
in the electron density of the Na+-free fXa structure 1fjs.
In fIXa the 186-loop is even further pulled away from the
expected Na+ site and fixed by a hydrogen bond formed by
Figure 4. Molecular Fingerprints Caused by Ca2+ Binding
(A) Superposition of the calcium-loaded (blue) and the calcium-free (yellow)
fIXa structure displays a reorientation of T76 and E77 upon EDTA treatment.
(B) Identification of the communication line connecting the active site and the
Ca2+ exosite in fIXa. The isomorphous difference electron density is contoured
at 3.5 s and identifies a significant clustering of changes in the scattering
power, caused by the extraction (or addition) of Ca2+. These changes are local-
ized along a communication line connecting the exosite (orange) with the
active site (inhibitor in green). Important residues involve D21-W141-V154,
V16-G193-D194 close to the activation pocket, and the C191-C220 disulfide
bond.
Figure 3. The Ethylene Glycol (EG) Binding Site of fIXa
(A) EG, bound at a groove near the 217-225 loop, overlaid with a 2Fobs  Fcalc-
density contoured at 1.0 s. Hydrogen bonds to S171, G217, and Y225 are
indicated.
(B) Overview on EG binding. The inhibitor FPR-CMK as well as coordinating
residues S171 and Y225 are represented in a stick model. See also Figure S4
for a depiction of the replacement of water molecules by EG.Structure 17, 1669–1678, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1673
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Structure and Mechanism of Xase-like fIXa MutantsFigure 5. Putative Na+-Binding Site in the
Xase-like Mutants and Sodium-Loaded fXa
(A) Overview of the 186-loop (gray) and the 217-
225 loop (red), both expected to be involved in
Na+ binding. The inhibitor is shown in orange,
and the sodium site coordinates are deduced
from the fXa structure 2bok (Scha¨rer et al., 2005).
(B) In the Xase-like mutants, three globular densi-
ties are observed in the structure, all of which do
not fulfill Na+-binding criteria such as octahedral
ligand coordination or bond length (Harding,
2001); these density features were interpreted as
water molecules. The 2Fobs  Fcalc density is con-
toured at 1.0 s. A detailed representation of the
electron density of the H185 – Y225 hydrogen
bond is given in Figure S3.
(C, D) A comparison of the solvent hydrogen-bond
network in fXa (C) and the Na+-soaked Xase-like
mutant structure (D). In fXa, two water molecules
complete the Na+ coordination. Formation of
a similar hydrogen bond network is prevented by
the twisted backbone conformation of E186,
G187, and G188 in fIXa, denoted as EGG motif.
Consistently, neither the expected sodium site
nor the sites of the two coordinating water mole-
cules exhibit electron density.
(E) Superposition of putative fIXa_2 (blue) and fXa
(yellow) sodium sites reveals subtle alterations due
to presence of the EGG motif in the 186-loop and
the H185-Y225 interaction. The hydrogen bond
between H185 and Y225 reinforces a H185
carbonyl group conformation incompatible with
Na+ binding.the side chains of His185 and Tyr225 (Figures 5A, 5D, and 5E,
electron density included in Figure S3). This conformation in
fIXa is incompatible with Na+ binding, when compared with fXa.
Furthermore, fIXa lacks two solvent molecules that complete
the octahedral coordination sphere of Na+ in the fXa-2bok struc-
ture. These water molecules are stabilized by several hydrogen
bonds, e.g., by the side chain of Asp189 and the carbonyl of
Lys186. Although the latter carbonyl is properly preoriented in
unloaded fXa, a 120 twist of the corresponding Gly187 pre-
cludes this interaction in fIXa; this twist propagates to the neigh-
boring residues Glu186 and Gly188, forming a conformationally
variable EGG-motif. The EGG motif and the His185-Tyr225
hydrogen bond together suppress sodium binding in fIXa
(Figures 5D and 5E).
DISCUSSION
Two-Step Activation in the Xase-like Mutants
The observed rearrangements in the Xase-like structures suggest
a two-step activation mechanism, as summarized in Figure 2.
This conclusion, and in particular the role of cofactor fVIIIa in
reordering the 99-loop of fIXa, is consistent with several lines of
evidence, including the mapping of cofactor interaction sites to
the 170-helix, especially including the flanking segment up to
Asn178 (Bajaj et al., 2001; Lefkowitz et al., 2001) and an observed
modification of the S4 site in fIXa upon cofactor complex forma-
tion (Fay and Koshibu, 1998; Mutucumarana et al., 1992).
The model shown in Figure 2 provides a straightforward expla-
nation why cofactor fVIIIa stimulates fIXa activity only toward fX,1674 Structure 17, 1669–1678, December 9, 2009 ª2009 Elsevier Ltbut not toward para-nitroanilide-based peptidic substrates lack-
ing primed-site interactions (Kolkman and Mertens, 2000). The
primed-site interactions are coupled with, and necessary for, the
99-loop reorientation via the Glu60-Tyr94 hydrogen bond. Conse-
quently, nonprimed site-directed substrates such as para-nitroa-
nilides are insufficient to provide the required co-stimulus of fIXa
even when present in the complex with its cofactor fVIIIa (Figure 6).
The activation mechanism by the Xase-like fIXa mutants (and
the physiological Xase complex) may be illustrated by a reversed
analogy with serpin inhibitors. Whereas serpins bind to the active
site and thereby distort the enzyme to result in an unproductive
enzyme-substrate complex (Huntington et al., 2000), the
cofactor fVIIIa acts as an ‘‘antiserpin’’ and reverses the distortion
of the fIXa active site by rearranging the 99-loop.
Ethylene Glycol Binding Augments the Active fIXa
Conformation
To better understand how EG binding can explain the enhanced
catalytic efficiency of fIXa, we have to consider the significant
flexibility present at the active site of wild-type fIXa (Brandstetter
et al., 1995; Hopfner et al., 1999). We propose that the stimu-
lating effect by EG derives from an accumulation and stabiliza-
tion of the active enzyme species. Consequently, the enzyme
populates a reduced conformational ensemble, leading to an
(unfavorable) loss in entropy; the latter is counterbalanced by
the release of water molecules from the EG binding site upon
EG binding (Figure S4).
This interpretation is in line with a partial disruption of the
EG-binding groove in zymogen and uninhibited fVIIa structuresd All rights reserved
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Structure and Mechanism of Xase-like fIXa Mutants(Eigenbrot et al., 2001; Sichler et al., 2002) which are likely to
affect the neighboring S1, S3 and S4 sites. EG-binding thus
provides another example of bi-directional allosteric active site
stabilization.
While the activity stimulation of fIXa (and fVIIa) by EG is not of
direct physiological relevance, it highlights the intrinsic plasticity
of these enzymes. In their solitary states, the proteins adopt
a structure and dynamics that is out of tune with the high activity
‘‘resonance’’ state; subtle modifications that may be exerted by
EG, Na+, the protein cofactor or substrate are able to tune in the
active site to a state of maximum activity.
Mapping the ‘‘Thermodynamic Linkage’’ between
the Ca2+ Site and Active Site
Bajaj and colleagues intensively studied the molecular cross-
talking of distinct metal sites (Ca2+, Na+) and the primary speci-
ficity pocket in fXa and aPC (Schmidt et al., 2002; Underwood
et al., 2000). Di Cera and coworkers succeeded to heal a partial
structural collapse caused by a mutation in the catalytic tetrad by
binding a fragment of the protease-activatable receptor PAR I to
the thrombin exosite I (Gandhi et al., 2008). Although these and
other elegant experiments revealed much about the nature of
these fascinating long-ranged allosteric effects in serine prote-
ases (‘‘thermodynamic linkage’’), the mapping of the signal
transduction pathways, and consequently their detailed mecha-
nism, had to rely largely on indirect evidence.
With the high degree of structural restraints and conservation
in the catalytic domain of serine proteases, it was clear that the
fingerprints of allosteric signal transduction are extremely hard
Figure 6. Realms of Substrate and Cofactors in the fIXa Activity
Regulation
The individual regulatory elements are assigned to a northern, equatorial, and
southern rim, depending on their distance and orientation with respect to the
substrate binding site. Each element is further (dominantly) influenced by
either cofactor or substrate, indicated by yellow and blue background. Further
details, including several lines of evidence supporting the proposed compo-
nent interaction model, are provided in the text.Structure 17, 1669–1to decipher. In fact, these fingerprints are mostly not evident
in actual changes of the atomic coordinates but only in the
dynamics of the participating residues. We, therefore, decided
to employ a crystallographic technique that eliminates most of
the errors that are introduced by interpreting crystallographic
raw data in terms of a discrete atomic model. By using isomor-
phous difference Fourier densities we could, for the first time,
detect a significant molecular fingerprint (R3.5 s changes)
that was induced by Ca2+ without relying on an additional model
bias.
The 186-Loop Acts as Molecular Switch Controlling
the Na+ Occupancy
With the high quality of the electron density at 1.5 A˚ resolution,
we were able to unambiguously determine the occupation of
sodium in the fIXa variants. Previous structures were solved to
3.0-2.8 A˚ resolution and remained inconclusive in this respect
(Brandstetter et al., 1995; Hopfner et al., 1999). We can rule
out that a metal ion was bound to the expected Na+ site even
in the presence of 1.5 M NaCl in our crystals.
The structure analysis revealed that the occupation of the Na+
site in fIXa is hindered by a double barrier: (i) The intact His185-
Tyr225 hydrogen bond fixes the carbonyls of the 185-loop in
a position incompatible with Na+-binding. For Na+ binding to
occur, the carbonyls of Tyr184a and His185 have to move for
approximately 2 A˚ toward the metal site, which implies a disrup-
tion of the His185-Tyr225 hydrogen bond. Additionally, (ii) Na+-
binding is hindered by a backbone conformation of Gly187 that
precludes the completion of hydrogen bonding network con-
tributing as sodium coordinators. The flexibility of this EGG motif
(Glu186-Gly187-Gly188) and the His185-Tyr225 hydrogen bond
together act as a molecular barrier controlling Na+ binding.
Possibly, cofactor fVIIIa is able to remove this barrier (Figure 6),
which would rationalize why the G187R point mutation renders
fIX hemophilic (Mukherjee et al., 2003).
Further support for the proposed switching mechanism
exerted by the His185-Tyr225 hydrogen bond is leant by a
Y225P mutant in fIXa that showed an 11-fold stimulation upon
Na+ binding (Schmidt et al., 2005). This observation is particu-
larly remarkable, as proline at position 225 will affect the back-
bone conformation and was shown to be evolutionary linked
with Na+ binding suppression (Dang and Di Cera, 1996). The
Y225P mutant represents a constitutively competent Na+ bind-
ing site where the Na+-binding brake is released. The interpreta-
tion of the kinetic data of the Y225P mutant is difficult, however,
because the described effect may be overlaid by a global desta-
bilization caused by the proline substitution. Based on the
proposed molecular switch mechanism for Na+ binding, we
expect that a Y225F mutant will increase the Na+ sensitivity in
fIXa without disturbing the overall structure.
Finally, it should be noted that the effect of sodium binding
may be different from stimulation of the enzymatic activity but
may possibly affect the cofactor binding affinity. In summary,
we present an extension and refinement of the original Tyr225/
Pro225 rule serving as a hallmark of sodium sensitivity (Dang
and Di Cera, 1996). Tyr225 is an indicator of sodium binding;
however, the presence or absence of a polar residue at 185
and the EGG motif at positions 186-188 present additional regu-
lation elements controlling sodium binding.678, December 9, 2009 ª2009 Elsevier Ltd All rights reserved 1675
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Cloning and Mutagenesis
Human full open reading frame factor IX clone EX-T0161-B02 was purchased
from RZPD (Berlin, Germany). A truncated construct including the EGF2
domain and activation peptide (residues 87abs–180abs) and the catalytic
domain (residues 16–245) was amplified by polymerase chain reaction (PCR)
and cloned into the pET 22b+ vector (Novagen). Mutations were introduced
following sequential rounds of the QuikChange site-directed mutagenesis
approach (Strategene) with the truncated construct as template.
Protein Expression and In Vitro Folding
FIXa_2 and fIXa_3 constructs were expressed in BL21 (DE3) cells (Novagen)
for 4 hr at 37C yielding inclusion bodies. The lysate was treated with DNase
I and inclusion bodies were washed twice with 100 mM Tris (pH 7.2), 20 mM
EDTA, 0.5 M NaCl, and 2% Triton X-100 (all Applichem). Inclusion bodies
then were solubilized with 7 M guanidinium HCl, 100 mM Tris (pH 8.5),
20 mM EDTA, and 100 mM b-mercaptoethanol. Following a pH shift to 3.5,
protein precipitated during dialysis against 100 volumes 20 mM EDTA
(pH 3.5), 100 mM NaCl. Resolubilization was performed with 7 M guanidinium
HCl, 100 mM Tris (pH 3.5), 20 mM EDTA to a final concentration of 10 mg/ml.
FIXa constructs were folded by drop-wise dilution into a folding buffer consist-
ing of 100 mM Tris, 0.5 M arginine, 100 mM NaCl, 20 mM CaCl2, 3 mM
cysteine, 0.3 mM cystine (pH 8.5) at 16C in three pulses with 24 hr intermittent
incubation.
Protein Purification and Activation
Following concentration to 200 ml using a Centramate cross-flow concen-
trator equipped with a 3 kDa cutoff membrane (Pall), the protein was dialyzed
against 20 mM Tris (pH 8.0), 5 mM CaCl2, 20 mM NaCl, 20 mM arginine. The
supernatant was loaded onto a Q-Sepharose ff column, the folded protein
passed in the flow-through. Release of the activation peptide was catalyzed
by RVV-X (Coachrom), incubated for 36 hr at a 1:50 molar dilution (Lenting
et al., 1995; Rezaie et al., 1993). The completely activated protein was
active-site inhibited with 5 mM D-FPR-chloromethylketone (FPR-CMK;
‘‘PPACK’’) or EGR-CMK (both Bachem). Next, an affinity purification using
heparin sepharose (GE Healthcare) was performed; the protein was eluted
with a linear gradient from 150 to 500 mM NaCl in 20 mM Tris (pH 7.4),
5 mM CaCl2. Final polishing was performed by size-exclusion chromatography
in 20 mM Tris, 2.5 mM CaCl2 and 25 mM NaCl. The proteins were concentrated
to 8 mg/ml (fIXa_2) and 6 mg/ml (fIXa_3), respectively.
Crystallization, Crystal Soaking and Data Collection, Structure
Solution
Initial crystals of both mutants were obtained with 30% PEG 8000, 100 mM Tris
(pH 8.5), but revealed severe (fIXa_2) as well as moderate (fIXa_3) tendency for
twinning. Optimization resulted in highest-quality crystals by mixing 0.8 ml
precipitant [24% PEG 6000, 100 mM MES (pH 7.1)] + 1.6 ml protein for
fIXa_2 and 0.8 ml precipitant [22% PEG 3000, 100 mM Bis/Tris (pH 6.85)] +
1.2 ml protein for fIXa_3 and equilibration against 500 ml of the respective
precipitant in a sitting drop vapor diffusion setup. Crystals grew to a size of
approximately 0.3 3 0.15 3 0.15 mm3 within 3 weeks at 20C.
Additive soaking (NaCl, EDTA, or EG) was performed 6-fold as an iterated
procedure where 0.2 ml of the additive (up to 3 M NaCl; up to 50 mM EDTA;
up to 30% ethylene glycol) plus 25% PEG 6000, 100 mM MES (pH 6.5) was
added to a drop containing FPR-CMK-inhibited fIXa_3 crystals as well as
100 ml of the same solution to the reservoir. Crystals were incubated for
12 hr between the soaking treatments. Crystal harvesting was carried out 72
hr following the last treatment. Crystals were flash-cooled in liquid nitrogen
and data were collected at 100 K, either in-house using a 345 mm MARdtb
image plate system (MAR Research, Hamburg) hooked up on a Bruker Micro-
star rotating anode system or at synchrotron sources (BESSY beam line 14.2,
Berlin, and the MPG beam line BW6, DESY/HASYLAB, Hamburg).
Diffraction data were evaluated using the MOSFLM and iMOSFLM pack-
ages (Leslie, 1992) followed by merging and scaling using the CCP4 suite
(CCP4, 1994). Crystals belong to the orthorhombic space group P 212121
with one molecule in the asymmetric unit. The structure of fIXa_3 was solved
by molecular replacement with MOLREP (Vagin and Teplyakov, 1997) using1676 Structure 17, 1669–1678, December 9, 2009 ª2009 Elsevier Lt1rfn as a search model. The structure was rebuilt using MAIN (Turk, 1992),
and refinement was carried out with CNS version 1.2 (Bru¨nger, 2007). All other
structures were solved by MR using fIXa_3 as new search model.
Crystal structure analysis has always to consider the possibility of crystal
artifacts, i.e., lattice contacts enforcing molecular conformations that would
not be observed in the solution state. We particularly examined this concern
in the significant rearrangements of the 99-loop and 60-loop, but also in the
putative sodium binding loops as well as the calcium loops. None of these
segments forms direct crystal contacts with neighboring protein molecules
in the lattice, weakening this caveat. Additionally, the observed rearrange-
ments at the 99-loop and 60-loop are identical in all six reported structures
(2wph–2wpm), where different active site-directed inhibitors, different ago-
nists such as EG and Ca2+ and different salt concentrations were present.
Together with the functional plausibility of the structures, we consider the pres-
ence of crystal artifacts as unlikely.
Detection of Static and Dynamic Structural Changes
by Isomorphous Difference Fourier Techniques
All fIXa variants, presented in this work, crystallized in a virtually identical
crystal system. Therefore, we could employ isomorphous difference Fourier
techniques to detect changes in the scattering behavior. Specifically, we
used a difference coefficient (Fobs
+Additive  Fobs-Additive) and phases 4+Additive
derived from the target crystal form. This procedure is—to a first approxima-
tion—independent from errors within the protein model and, therefore, very
robust and allows to identify small variations between the compared crystal
forms. The absolute value of this difference density was employed to detect
changes in the dynamics of amino acids with identical conformation, because
the dynamics will affect the scattering power. Thus, this procedure presents
a fundamental advancement toward the comparison of crystal structure coor-
dinates, which can only detect changes in the static structure. Furthermore,
this procedure is well suited to detect changes in the solvent structure, which
is generally difficult to model in a discrete atomic structure.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been deposited in the Protein
Data Bank with accession codes 2wph, 2wpi, 2wpj, 2wpk, 2wpl, and 2wpm.
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Supplemental Data include four figures and can be found with this article online
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